Weight Watchers, and Noom, long advocates of lifestyle change focusing on diet and exercise have added prescription weight loss drugs approved to treat obesity, such as Wegovy and Ozempic
Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
Shortness of Breath and Heart Palpitations: Anemia caused by B12 deficiency can lead to symptoms such as shortness of breath, heart palpitations, or chest pain due to decreased oxygen-carrying capacity of the blood
PUFAs are essential for the human body and serve critical roles in various cellular functions